Milestone Scientific Inc

NYSE American:MLSSUnited States

May 16, 2024

Show headlines and story abstract

• Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024, from 7:00AM ET on Thursday May 16, 2024 by Dow Jones

  7:00AM ET on Thursday May 16, 2024 by Dow Jones
  Companies Mentioned: MLSS
  lease liabilities 8,219 10,264 Current portion of operating lease liabilities 107,355 103,427 ------------ -------------- Total current liabilities 3,636,603 3,076,713 Non-current portion of finance lease liabilities - 434 Non-current portion of operating lease liabilities 253,774 281,853 ------------ -------------- Total liabilities $ 3,890,377 $ 3,359,000 Commitments Stockholders' equity Common stock, par value $0.001; authorized 100,000,000 shares; 76,632,279 shares issued and 76,598,946 shares outstanding as of March 31, 2024 shares; 75,881,840 shares issued and 75,848,507 shares outstanding as of December 31, 2023; 76,632 75,881 Additional paid in capital 133,075,331 132,187,656 Accumulated deficit (124,780,038) (123,339,509) Treasury stock, at cost, 33,333 shares (911,516) (911,516) ------------ -------------- Total Milestone Scientific, Inc. stockholders' equity 7,460,409 8,012,512 Total liabilities and stockholders' equity $ 11,350,786 $ 11,371,512 ============ ============== MILESTONE SCIENTIFIC AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR YEARS ENDED DECEMBER 31, (UNAUDITED) For the three months ended For the three months ended March 31, 2024 March 31, 2023 Product sales, net $ 2,248,845 $ 2,597,598 Cost of products sold 572,742 708,135 --- ----------------- --- ----------------- Gross profit 1,676,103 1,889,463 Selling, general and administrative expenses 3,035,276 3,074,572 Research and development expenses 94,211 140,347 Depreciation and amortization expense 11,684 17,220 --- ----------------- --- ----------------- Total operating expenses 3,141,171 3,232,139 Loss from operations (1,465,068) (1,342,676) Interest income (expense) (3,351) 23,345 Unrealized Gain Treasury investment 27,890 - --- ----------------- --- ----------------- Loss before provision for income taxes (1,440,529) (1,319,331) Provision for income taxes - - --- ----------------- --- ----------------- Net loss (1,440,529) (1,319,331) Net loss attributable to noncontrolling interests - (11,665) --- ----------------- --- ----------------- Net loss attributable to Milestone Scientific Inc. $ (1,440,529) $ (1,307,666) === ================= === ================= Net loss per share applicable to common stockholders-- Basic and Diluted (0.02) (0.02) Weighted average shares outstanding and to be issued-- Basic and Diluted 79,738,551 72,104,234
  

• Press Release: Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024, from 7:00AM ET on Thursday May 16, 2024 by Dow Jones

  7:00AM ET on Thursday May 16, 2024 by Dow Jones
  Companies Mentioned: MLSS